LecTec Initiates R&D On Hand Sanitizer Patch

To support its R&D program, LecTec has established relationships with bio-medical companies based in China, Japan, Thailand and the US, to assist the company in developing its antimicrobial materials. In addition, LecTec has selected a US based laboratory to conduct the testing of its hand sanitizer patch product, as well as a leading regulatory consulting firm that specializes in antimicrobial product approvals, to provide additional support.

The company has also engaged an India-based firm to explore R&D opportunities in India and to analyze its existing and emerging IP portfolio.

Daniel Sigg, chief scientific officer of LecTec, said: “To date, we have identified an interesting array of potential antimicrobial technologies, and companies in support of our antimicrobial patch product concept. Many of the technologies and companies are based in Asia, but we will test and compare these technologies in our US-based testing laboratory for their antimicrobial efficacy, and are looking forward to the results over the next few weeks and months. While the interest of numerous companies in our product concept is encouraging, we need to realize that we are still early in the process, and that significant scientific, clinical, and regulatory risks on commercializing such a product remain.”

Judd Berlin, CEO of LecTec, said: “We are consulting with major fast food restaurant chains in designing a hand sanitizer patch for use by kitchen crew. The restaurant industry is large and relentless about hand sanitation. The restaurant industry employs about 13 million people in America and on a typical day in America more than 130 million individuals are restaurant patrons.

“Our investment in R&D will provide clarity on the feasibility of our hand sanitizer patch concept. LecTec has only recently been financially able to fully operate as an R&D company and so results of our first R&D venture will be a determining factor in developing our M&A and management succession plans.”